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Background: Campylobacter jejuni and Campylobacter coli are identified as the major causes of acute gastroenteritis in humans. 
Because of the fastidious nature of Campylobacters, many clinical laboratories fail to routinely culture them. The detection of 
Campylobacter spp. using molecular-based techniques can be useful for diagnostic and epidemiological applications. This study aimed to 
develop a multiplex PCR assay for the simultaneous detection of C. jejuni and C. coli strains from clinical specimens. 
Materials and Methods: During a 19-month period, stool samples were collected from 980 children admitted to a hospital in Tehran, 
Iran and then examined. The samples were cultured on both Brucella agar and Modified Charcoal-Cefoperazone-Deoxycholate 
agar (mCCDA) media at 42°C for 48 h. To confirm suspected bacteria, Gram staining and other biochemical tests were carried out. 
Finally, after extracting DNA from pure cultures using the boiling method, the multiplex PCR assay was performed. 
Results: The multiplex PCR assay showed that Campylobacter spp. can be detected using 400 bp target product of cadF. It can also 
accurately distinguish between C. jejuni and C. coli species with different bands of 735 bp and 500 bp using hipO and asp genes, 
respectively. 
Conclusions: Results showed that the multiplex PCR assay can replace the biochemical assays for differentiating between C. jejuni and 
C. coli strains in a single-step PCR test. 
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1. Background 
Campylobacter spp. is a common cause of acute 
gastroenteritis worldwide (1). Among various pathogenic 
Campylobacter species in humans, the thermophilic 
Campylobacter jejuni and Campylobacter coli are recognized 
as the major cause of human campylobacteriosis (2). 
The major reservoir and source of Campylobacters for 
humans are poultry and poultry products. Undercooked poultry 
meat, unpasteurized milk, and water can be considered as the 
sources of human infection with C. jejuni and C. coli (3). 
The gastrointestinal manifestations of campylobacteriosis 
disease include cramps, fever, myalgia, weight loss, acute 
watery or bloody diarrhea; however, the infection may result 
in severe extra-intestinal sequelae, especially acute immune-
mediated neurologic complications such as Guillain-Barre and 
Miller Fisher syndromes, due to cross-reactivity between the 
bacterial lipooligosaccharides and nervous system gangl-
iosides (4).  
Isolation of Campylobacters using the culture method is 
considered the gold standard for campylobacteriosis disease 
diagnosis; however, it has several limitations because of the 
fastidious nature of Campylobacters (5). Furthermore, due to 
the phylogenetic relatedness of C. jejuni and C. coli species, 
the identification of Campylobacter at species level using 
biochemical assays is difficult (6). Therefore, other 
techniques such as PCR and real-time PCR are used as the 
methods for Campylobacter identification, showing a very 
high sensitivity (7-8).   
Differentiation of Campylobacter spp. using molecular-
based assays can be useful for rapid and specific detection and  
epidemiological applications. For this purpose, various genes 
including fliY, cdt, asp, hipO , glyA, ceuE, cadF  are used (9).  
The asp gene encodes aspartokinase enzyme and is highly 
specific for C. coli. Hippuricase is produced by the hipO gene  
 
in C. jejuni (a species-specific hippurate hydrolase enzyme), 
which is absent in C. coli. The cadF gene also encodes a 
fibronectin-binding protein that can promote the attachment of 
the microorganism to eukaryote cells. It has been described as 
a conserved and genus-specific gene (10-12).  
 
2. Objectives 
The aim of this study was to differentiate between C. jejuni 
and C. coli species  using  a  set  of  specific  primers  for  asp, 
hipO, and cadF genes in a multiplex PCR assay. 
 
3. Materials and Methods  
3.1. Sampling and growth conditions 
During a 19-month period (June 2012-January 2014), 980 
children with intestinal signs were admitted to one of the 
major hospitals in Tehran, Iran. 750 suspected cases to 
campylobacteriosis were included in this study. After 
collecting the samples, the stool specimens using Carry-Blair 
Transport media (Micro Media, Hungary) were transferred to 
the microbiological laboratory and then cultured 
immediately on Brucella agar (Merck, Germany) with 5% 
sheep blood and Modified Charcoal–Cefoperazone-
Deoxycholate agar (mCCDA) (Merck, Germany). The plates 
were incubated at 42°C for 48 h under microaerobic 
conditions in a sealed jar using gas packs (Merck, Germany). 
Both of the media were supplemented with vancomycin, 
polymyxin B, and trimethoprim (pH 7.2±0.2). Suspected 
colonies to Campylobacter spp. were confirmed using Gram 
staining and spiral morphology, catalase and oxidase 
positive, nitrate reduction positive, and indoxyl acetate 
hydrolysis positive. For differenting between them at species 
level, hippurate hydrolysis test positive (C. jejuni) and 
negative (C. coli) as well as susceptiblity to nalidixic 
acid (C. coli) were used. 
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3.2. DNA extraction and multiplex PCR assay  
DNA extraction from pure cultures of Campylobacter isolates 
was performed by the boiling method in 200 μL sterile distilled 
water and boiled for 15 min at 100°C. Suspension was then 
centrifuged at 13,000 g at room temperature for 10 min, and the 
supernatant was used as template DNA in multiple PCR assay. 
The multiplex PCR was carried out within a thermal cycler 
(Eppendorf, Germany) in a 25-μL reaction mixture containing 10 
mg of DNA template, 2.5 μL PCR buffer 10X, 200 μM dNTP, 5 
mM MgCl2, 0.1 μM of specific primers (Table 1), 1 unit of Taq 
DNA polymerase and sterile deionized water.  
Amplification conditions for the three genes (asp, hipO, and 
cadF)  were  as  follow:  95°C  for  5  min,  followed  by  30  
amplification cycles; denaturation at 95°C for 45 seconds, 
annealing at 48°C for 30 seconds, and extension at 72°C for 30 
seconds. Finally, an additional extension step (5 min, 72°C) was 
performed. Finally, amplicons were electrophoresed on 1% 
agarose gel. C. coli ATCC 43478 and C. jejuni subsp. jejuni 
ATCC 29428 were used as reference strains. 
 
4. Results 
Among studied population, 750 children had bacterial 
systemic and gastrointestinal symptoms including fever, 
abdominal pain, vomiting, diarrhea with high WBC and RBC 
count. From a total of 750 cases, 48.5 and 51.5% were male and 
female, respectively, with an average age of ~6 years. According 
to the culture results, the number of Campylobacter positive cases 
was 35, in which 33 cases (94 %) were infected by C. jejuni, and 
2 cases (6 %) were infected by C. coli. About 50% of the bacteria 
were isolated by each of the media (Brucella agar and mCCDA). 
Most of the positive cases occurred during the summer season 
from July to September.     
The multiplex PCR assay showed that Campylobacter spp. can 
be detected using 400 bp target product of cadF. It can also 
accurately distinguish between C. jejuni and C. coli species with 
different bands of 735 bp and 500 bp using hipO and asp genes, 
respectively (Fig.1).  
 
5. Discussion 
Campylobacter species have currently been reported as the 
most common causes of acute bacterial gastroenteritis worldwide 
both in developing and developed countries. Some studies showed 
that gastrointestinal infection caused by C. jejuni leads to the high 
levels of morbidity and mortality. About 2 million cases are 
annually reported to be infected by C. jejuni  with a mortality rate 
greater than 2,000 people (13). 
Although biochemical tests such as hippurate hydrolysis are 
useful for the differentiation of Campylobacters at the species 
level, they could also be used for the identification of hippurate 
hydrolysis-negative strains of C. jejuni and false-positive isolates 
(14). Another disadvantage of conventional tests is that they are 
extremely time consuming. In this study, the time required for the 
identification of Campylobacter at the species level from a sample 
was approximately 4 days.  
In addition, the accurate differentiation between two 
Campylobacter species is important for the following treatment of 
the disease in human. For example erythromycin is used for treating 
C. jejuni infection, while C. coli strains are resistant to this antibiotic 
(6). Therefore, an accurate molecular method can be easily used for 
clinical diagnosis and appropriate treatment of the disease.  
In some previous studies, only one gene was used for 
differentiating between C. jejuni and C. coli strains. Klena et al. 
(2004) used divergent and conserved regions of lpxA gene of the 
lipid A, encoding a UDP-N- acetyl glucosamine acyl transferase, 
to differentiate between C. coli, C. jejuni, C. lari, and C. 
upsaliensis strains using a multiplex PCR. In another study 
conducted by Shams et al. (2016), conserved regions of the cadF 
gene were used for the detection and differentiation between C. 
jejuni and C. coli species. In another study, Gonzalez et al. (1997) 
also discriminated between both C. jejuni and C.  coli species 
using the ceuE gene (7, 15-16). 
Our study is similar to Al Amri et al. (2007) who used a 
combination of the genus-specific virulence gene (cadF) 
together with the hippuricase gene (C. jejuni) and the 
aspartokinase gene (C. coli), respectively. The same PCR 
assay was developed to detect isolated strains from Iranian 
patients (10). Other genes have also been used for 
distinguishing Campylobacter spp. by multiplex PCR 
method. For example, Cloak et al. (2002) developed a 
multiplex PCR method using the cadF gene of pathogenic 
Campylobacter spp and a specific but undefined gene of C. 
jejuni and the ceuE gene of C. coli. The lpxA, hipO, and glyA 
genes were used by Adzitey et al. (2011) to differentiate 
between C. jejuni and C. coli species. In another study, 
ceuE, cadF, and oxidoreductase subunit genes were used for 
the differentiation purpose (6, 17-18).  
In all mentioned studies the multiplex PCRs were able to 
amplify products with different sizes which can be concurrently 
visualized on the agarose gel without extra reaction and 
electrophoresis. Thus, it could be considered as a significant 
advantage over single-species identification systems for the 
evaluation of the disease in a large number of clinical specimens. 
 
6. Conclusion 
The designed multiplex PCR assay in this study is a sensitive 
and specific tool which can be useful for the rapid and 
simultaneous detection and differentiation of C. jejuni and C. coli 
species in clinical settings. 
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Table 1. Nucleotide sequences of the primers used in the multiplex PCR assay. 
Primer Sequence ( 5' to 3' ) Size of product (bp) 
Targets 
Annealing temperature (°C) 
Gene Bacteria 
cadF -F 
cadF -R 
TTGAAGGTAATTTAGATATG 
CTAATACCTAAAGTTGAAAC 400 cadF C. jejuni & C. coli 43 
asp-F 
asp-R 
GGTATGATTTCTACAAAGCGAG 
ATAAAAGACTATCGTCGCGTG 500 asp C. coli 43 
hipO -F 
hipO -R 
GAAGAGGGTTTGGGTGGTG 
AGCTAGCTTCGCATAATAACTTG 735 hipO C. jejuni 43 
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Fig. 1: Gel electrophoresis of the multiplex PCR.  Lane 1, 
400 bp fragment of the cadF gene of Campylobacter spp.  
and 735 bp target of hipO ; lane 2, 400-bp fragment of 
the cadF  gene of Campylobacter spp. and 500 bp fragment 
of asp gene; lane NC, Negative Control, lane M, 1 kb 
molecular weight marker. 
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